SEC 13F · Q3 2026

Health Care Stocks Held by Hedge Funds

All health care-sector stocks held by tracked institutional funds per the latest SEC 13F filings, sorted by number of fund holders.

OFIX Orthofix Medical
6.34 -4.08%
Health Care 1M -34.9%
101Funds Holding
$173.45MInstitutional value
-45vs last quarter
Millennium Management AQR Capital Management Arrowstreet Capital Renaissance Technologies +97 View holders →
RXST Rxsight
4.61 -7.98%
Health Care 1M -5.9%
101Funds Holding
$112.33MInstitutional value
-56vs last quarter
Millennium Management D. E. Shaw & Co AQR Capital Management Marshall Wace +97 View holders →
USNA Usana Health Sciences
13.16 -0.45%
Health Care 1M -7.5%
101Funds Holding
$130.84MInstitutional value
-41vs last quarter
Renaissance Technologies D. E. Shaw & Co Marshall Wace AQR Capital Management +97 View holders →
ARDT Ardent Health
14.50 +0.69%
Health Care 1M +20.2%
100Funds Holding
$245.12MInstitutional value
-44vs last quarter
AQR Capital Management Arrowstreet Capital D. E. Shaw & Co Millennium Management +96 View holders →
CBLL Ceribell
25.75 +0.47%
Health Care 1M -5.1%
100Funds Holding
$619.34MInstitutional value
-32vs last quarter
Millennium Management D. E. Shaw & Co AQR Capital Management Arrowstreet Capital +96 View holders →
FLGT Fulgent Genetics
24.78 -1.39%
Health Care 1M +23.1%
100Funds Holding
$193.37MInstitutional value
-47vs last quarter
D. E. Shaw & Co Millennium Management AQR Capital Management +97 View holders →
KROS Keros Therapeutics
11.39 -5.08%
Health Care 1M +1.9%
100Funds Holding
$159.64MInstitutional value
-38vs last quarter
AQR Capital Management Renaissance Technologies D. E. Shaw & Co Arrowstreet Capital +96 View holders →
LBRX Lb Pharmaceuticals
40.04 -0.05%
Health Care 1M +2.1%
100Funds Holding
$587.87MInstitutional value
-21vs last quarter
Farallon Capital Management Millennium Management D. E. Shaw & Co Marshall Wace +96 View holders →
MAZE Maze Therapeutics
32.43 +3.94%
Health Care 1M -0.5%
100Funds Holding
$530.48MInstitutional value
-69vs last quarter
Marshall Wace Farallon Capital Management Millennium Management AQR Capital Management +96 View holders →
KIDS Orthopediatrics
32.51 +2.72%
Health Care 1M +36.4%
99Funds Holding
$245.69MInstitutional value
-28vs last quarter
Millennium Management D. E. Shaw & Co AQR Capital Management +96 View holders →
SGMT Sagimet Biosciences
9.62 -4.85%
Health Care 1M -3.7%
99Funds Holding
$348.06MInstitutional value
-33vs last quarter
D. E. Shaw & Co Marshall Wace Millennium Management Farallon Capital Management +95 View holders →
CCCC C4 Therapeutics
2.44 -1.41%
Health Care 1M -23.0%
98Funds Holding
$215.36MInstitutional value
-58vs last quarter
D. E. Shaw & Co Renaissance Technologies Marshall Wace AQR Capital Management +94 View holders →
IVVD Invivyd
0.45 -5.23%
Health Care 1M -30.2%
98Funds Holding
$85.84MInstitutional value
-34vs last quarter
Maverick Capital AQR Capital Management Renaissance Technologies Millennium Management +94 View holders →
LENZ Lenz Therapeutics
3.34 +4.05%
Health Care 1M +3.7%
98Funds Holding
$80.29MInstitutional value
-56vs last quarter
Millennium Management Marshall Wace D. E. Shaw & Co Renaissance Technologies +94 View holders →
NATR Natures Sunshine Prods
10.17 -1.45%
Health Care 1M -17.0%
98Funds Holding
$146.27MInstitutional value
-58vs last quarter
Renaissance Technologies Arrowstreet Capital Millennium Management AQR Capital Management +94 View holders →
NRC Nrc Health
24.99 -4.47%
Health Care 1M +23.0%
98Funds Holding
$203.60MInstitutional value
-29vs last quarter
Renaissance Technologies Arrowstreet Capital AQR Capital Management Millennium Management +94 View holders →
RNA Atrium Therapeutics
6.98 +5.12%
Health Care 1M -12.7%
98Funds Holding
$55.87MInstitutional value
-61vs last quarter
Millennium Management Marshall Wace AQR Capital Management Renaissance Technologies +94 View holders →
SENS Senseonics Holdings
8.90 -8.57%
Health Care 1M +11.7%
98Funds Holding
$133.39MInstitutional value
-17vs last quarter
Millennium Management Marshall Wace AQR Capital Management D. E. Shaw & Co +94 View holders →
UTMD Utah Med Prods
70.96 -1.77%
Health Care 1M -5.0%
98Funds Holding
$110.64MInstitutional value
-21vs last quarter
Renaissance Technologies Arrowstreet Capital AQR Capital Management D. E. Shaw & Co +94 View holders →
AGEN Agenus
6.14 -4.06%
Health Care 1M -4.1%
96Funds Holding
$165.93MInstitutional value
-14vs last quarter
Marshall Wace Renaissance Technologies D. E. Shaw & Co AQR Capital Management +92 View holders →
AVR Anteris Technologies Global
5.09 -2.30%
Health Care 1M -15.3%
96Funds Holding
$261.88MInstitutional value
-49vs last quarter
Renaissance Technologies AQR Capital Management Millennium Management +93 View holders →
ACH Accendra Health
0.09 -34.08%
Health Care 1M -64.3%
95Funds Holding
$21.19MInstitutional value
-50vs last quarter
D. E. Shaw & Co Marshall Wace AQR Capital Management Renaissance Technologies +91 View holders →
AVTX Avalo Therapeutics
6.75 +0.75%
Health Care 1M -44.9%
95Funds Holding
$540.86MInstitutional value
-41vs last quarter
Farallon Capital Management Millennium Management Renaissance Technologies +92 View holders →
ELMD Electromed
23.26 -0.60%
Health Care 1M -14.9%
95Funds Holding
$105.35MInstitutional value
-41vs last quarter
Arrowstreet Capital Renaissance Technologies AQR Capital Management +92 View holders →
NAGE Niagen Bioscience
1.87 -3.61%
Health Care 1M -24.3%
95Funds Holding
$74.33MInstitutional value
-51vs last quarter
Marshall Wace Renaissance Technologies AQR Capital Management D. E. Shaw & Co +91 View holders →
RZLT Rezolute
4.20 -1.18%
Health Care 1M +13.5%
94Funds Holding
$203.89MInstitutional value
-60vs last quarter
D. E. Shaw & Co Millennium Management AQR Capital Management Marshall Wace +90 View holders →
CLPT Clearpoint Neuro
7.31 -5.19%
Health Care 1M -21.0%
93Funds Holding
$118.75MInstitutional value
-44vs last quarter
Marshall Wace Millennium Management AQR Capital Management +90 View holders →
ENTA Enanta Pharmaceuticals
7.98 -3.04%
Health Care 1M -29.4%
92Funds Holding
$187.14MInstitutional value
-38vs last quarter
Farallon Capital Management Millennium Management Renaissance Technologies AQR Capital Management +88 View holders →
IMMX Immix Biopharma
7.04 -0.98%
Health Care 1M -17.3%
92Funds Holding
$340.81MInstitutional value
-22vs last quarter
Marshall Wace D. E. Shaw & Co Millennium Management Arrowstreet Capital +88 View holders →
SGHT Sight Sciences
10.62 -1.39%
Health Care 1M +22.1%
92Funds Holding
$141.61MInstitutional value
-28vs last quarter
Millennium Management D. E. Shaw & Co AQR Capital Management Renaissance Technologies +88 View holders →
TMCI Treace Med Concepts
4.35 -3.97%
Health Care 1M +5.1%
92Funds Holding
$80.96MInstitutional value
-32vs last quarter
Millennium Management Marshall Wace D. E. Shaw & Co AQR Capital Management +88 View holders →
ANRO Alto Neuroscience
26.51 +2.32%
Health Care 1M +13.7%
91Funds Holding
$517.94MInstitutional value
-31vs last quarter
Alpha Wave Global, LP BlackRock Inc VANGUARD CAPITAL MANAGEMENT LLC SP +87 View holders →
DSGN Design Therapeutics
9.32 -1.58%
Health Care 1M -13.1%
90Funds Holding
$300.07MInstitutional value
-54vs last quarter
Renaissance Technologies D. E. Shaw & Co AQR Capital Management +87 View holders →
SION Sionna Therapeutics
2.97 +0.00%
Health Care 1M -23.3%
90Funds Holding
$98.08MInstitutional value
-69vs last quarter
Viking Global Investors Millennium Management Marshall Wace AQR Capital Management +86 View holders →
TRDA Entrada Therapeutics
4.64 -7.75%
Health Care 1M -0.2%
90Funds Holding
$90.87MInstitutional value
-46vs last quarter
AQR Capital Management Millennium Management Renaissance Technologies D. E. Shaw & Co +86 View holders →
UPB Upstream Bio
2.00 -3.85%
Health Care 1M -28.6%
90Funds Holding
$170.00MInstitutional value
-67vs last quarter
D. E. Shaw & Co Millennium Management AQR Capital Management Renaissance Technologies +86 View holders →
ACHV Achieve Life Science
6.40 -5.60%
Health Care 1M -9.3%
89Funds Holding
$375.44MInstitutional value
-30vs last quarter
Marshall Wace Renaissance Technologies AQR Capital Management +86 View holders →
INNV Innovage Hldg
8.91 +0.00%
Health Care 1M -2.5%
89Funds Holding
$157.00MInstitutional value
-25vs last quarter
Millennium Management Arrowstreet Capital Marshall Wace Renaissance Technologies +85 View holders →
KYTX Kyverna Therapeutics
4.37 -2.46%
Health Care 1M -25.2%
89Funds Holding
$163.38MInstitutional value
-38vs last quarter
Millennium Management Renaissance Technologies D. E. Shaw & Co Marshall Wace +85 View holders →
INFU Infusystem Holdings
14.06 -4.16%
Health Care 1M +0.1%
88Funds Holding
$157.22MInstitutional value
-14vs last quarter
Renaissance Technologies Arrowstreet Capital AQR Capital Management +85 View holders →
RLMD Relmada Therapeutics
3.11 +8.93%
Health Care 1M -3.1%
88Funds Holding
$193.21MInstitutional value
-46vs last quarter
Millennium Management Marshall Wace Renaissance Technologies D. E. Shaw & Co +84 View holders →
KLRA Kailera Therapeutics
11.58 -1.78%
Health Care 1M -10.4%
87Funds Holding
$409.94MInstitutional value
-19vs last quarter
Farallon Capital Management Marshall Wace Millennium Management Renaissance Technologies +83 View holders →
LUCD Lucid Diagnostics
0.39 -5.25%
Health Care 1M +16.0%
87Funds Holding
$30.17MInstitutional value
-34vs last quarter
BlackRock Inc VANGUARD CAPITAL MANAGEMENT LLC Two Seas Capital LP Aberdeen Group plc +83 View holders →
MGNX Macrogenics
1.98 +0.51%
Health Care 1M -44.8%
87Funds Holding
$113.81MInstitutional value
-40vs last quarter
Renaissance Technologies Marshall Wace Millennium Management D. E. Shaw & Co +83 View holders →
NMRA Neumora Therapeutics
0.35 -5.40%
Health Care 1M -16.6%
87Funds Holding
$38.50MInstitutional value
-31vs last quarter
AQR Capital Management Renaissance Technologies Marshall Wace Millennium Management +83 View holders →
ORGO Organogenesis Holdings
0.79 -7.50%
Health Care 1M -20.4%
87Funds Holding
$63.14MInstitutional value
-52vs last quarter
D. E. Shaw & Co AQR Capital Management Renaissance Technologies Millennium Management +83 View holders →
VYGR Voyager Therapeutics
1.61 -3.59%
Health Care 1M -20.3%
87Funds Holding
$64.10MInstitutional value
-57vs last quarter
Millennium Management Renaissance Technologies Marshall Wace AQR Capital Management +83 View holders →
ALEC Alector
2.30 -10.51%
Health Care 1M +23.0%
86Funds Holding
$86.24MInstitutional value
-61vs last quarter
Millennium Management D. E. Shaw & Co Renaissance Technologies Marshall Wace +82 View holders →
CLYM Climb Bio
9.28 -0.22%
Health Care 1M -14.6%
86Funds Holding
$378.89MInstitutional value
-28vs last quarter
Marshall Wace D. E. Shaw & Co Millennium Management Renaissance Technologies +82 View holders →
GALT Galectin Therapeutics
2.81 -5.70%
Health Care 1M -16.6%
86Funds Holding
$55.20MInstitutional value
-19vs last quarter
Marshall Wace Renaissance Technologies +84 View holders →

1036 stocks in Health Care · prices as of 2026-11-19